Dmitrii Pavlov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Dmitrii Pavlov has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Abrar Haque
Hotchkins Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada
1 shared publication - Alan Harzman
Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, Ohio
1 shared publication - Aleksei Umriukhin
Department of Normal Physiology, Sechenov University, 119048 Moscow, Russia
1 shared publication - Alexander M. Dudchenko
Laboratory of General Pathology of Cardiorespiratory System, Institute of General Pathology and Pathophysiology, Baltiyskaya, 8, 125315 Moscow, Russia
1 shared publication - Alexey Vasilievich Deykin
Laboratory of Genetic Technology and gene editing for Biomedicine and Veterinary, National Research Belgorod state University, 308015 Belgorod, Russia
1 shared publication - Almagul Kushugulova
Laboratory of Microbiome, Center for Life Sciences, National Laboratory Astana, Nazarbayev University
1 shared publication
Latest Publications
- Open Access
- 14 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9092
Chronic Ultrasound (‘Emotional’) Stress in Mice Exacerbates Colitis Through GSK3β-Mediated Neuroimmune Dysregulation and Is Ameliorated by Probiotic Intervention
Background: Growing evidence supports a bidirectional relationship between ‘emotional’ (psychological) stress and intestinal inflammation. ‘Emotional stress’, a form of stress that is triggered by negative information and experiences of non-physical nature, is an established risk factor for the development of subclinical intestinal inflammation, called irritable bowel syndrome (IBS), to inflammatory bowel disease (IBD). However, the underlying mechanisms of this transition remain unclear, owing to the limited availability of appropriate animal models. Glycogen synthase kinase-3β (GSK3β), a molecular hub of ‘emotional stress’ response, as shown particularly in the ultrasound stress (US) model, and an important player in gut inflammation, may underlie this transition. Here, we propose a mouse paradigm for the progression from IBS to IBD-like syndrome by combining the US with dextran sulfate sodium (DSS)-induced colitis paradigm in mice and investigate the role of GSK3β signaling under these conditions. Methods: C57BL/6 mice were subjected to a 21-day US consisting of irradiation of alternating ‘negative’ and ‘neutral’ frequencies, followed by 5 days of 0.5% DSS exposure via drinking water. A standardized anti-inflammatory probiotic VSL#3 whose efficacy was shown in DSS-based models was administered to a subgroup of mice. Behavioral, histological, and molecular outcomes previously established in US and IBS models were evaluated. This included parameters of anxiety, anhedonia, time of intestinal transit, fecal water content, and brain and gut neutrophil infiltration, as well as gene expression of pro-inflammatory cytokines and of GSK3β, and serum levels of pro-inflammatory molecules. Given the important role of the nervus vagus in brain–gut interactions, molecular changes were studied in the nervus vagus as well. Results: Mice exposed to the combined US and DSS challenge had impaired intestinal transit and increased fecal water content, neutrophil infiltration, the upregulation of pro-inflammatory mediators and GSK3β in the gut that together manifested the IBD-like state. In this group, upregulated gene expression of these markers was found in the prefrontal cortex and the hippocampus, as well as in the vagus. The combined US and DSS challenge exacerbated anxiety- and anhedonia-like behaviors and elevated blood cytokine and chemokine levels. In comparison to these changes, solitary exposures to US or DSS exerted smaller effects on the majority of measured parameters. Probiotic treatment attenuated most of the physiological, inflammatory, and behavioral abnormalities induced by the combined US and DSS intervention. Conclusions: The mouse model employed here using both US and DSS recapitulated the progression of IBS to the IBD associated with ‘emotional stress’ and demonstrated upregulated gut and brain Gsk3β expression accompanying this transition. The described model provides a useful paradigm for investigating the mechanisms underlying the disease development from IBS- to IBD-like pathology.
- 14 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9092
Open AccessChronic Ultrasound (‘Emotional’) Stress in Mice Exacerbates Colitis Through GSK3β-Mediated Neuroimmune Dysregulation and Is Ameliorated by Probiotic Intervention
Background: Growing evidence supports a bidirectional relationship between ‘emotional’ (psychological) stress and intestinal inflammation. ‘Emotional stress’, a form of stress that is triggered by negative information and experiences of non-physical nature, is an established risk factor for the development of subclinical intestinal inflammation, called irritable bowel syndrome (IBS), to inflammatory bowel disease (IBD). However, the underlying mechanisms of this transition remain unclear, owing to the limited availability of appropriate animal models. Glycogen synthase kinase-3β (GSK3β), a molecular hub of ‘emotional stress’ response, as shown particularly in the ultrasound stress (US) model, and an important player in gut inflammation, may underlie this transition. Here, we propose a mouse paradigm for the progression from IBS to IBD-like syndrome by combining the US with dextran sulfate sodium (DSS)-induced colitis paradigm in mice and investigate the role of GSK3β signaling under these conditions. Methods: C57BL/6 mice were subjected to a 21-day US consisting of irradiation of alternating ‘negative’ and ‘neutral’ frequencies, followed by 5 days of 0.5% DSS exposure via drinking water. A standardized anti-inflammatory probiotic VSL#3 whose efficacy was shown in DSS-based models was administered to a subgroup of mice. Behavioral, histological, and molecular outcomes previously established in US and IBS models were evaluated. This included parameters of anxiety, anhedonia, time of intestinal transit, fecal water content, and brain and gut neutrophil infiltration, as well as gene expression of pro-inflammatory cytokines and of GSK3β, and serum levels of pro-inflammatory molecules. Given the important role of the nervus vagus in brain–gut interactions, molecular changes were studied in the nervus vagus as well. Results: Mice exposed to the combined US and DSS challenge had impaired intestinal transit and increased fecal water content, neutrophil infiltration, the upregulation of pro-inflammatory mediators and GSK3β in the gut that together manifested the IBD-like state. In this group, upregulated gene expression of these markers was found in the prefrontal cortex and the hippocampus, as well as in the vagus. The combined US and DSS challenge exacerbated anxiety- and anhedonia-like behaviors and elevated blood cytokine and chemokine levels. In comparison to these changes, solitary exposures to US or DSS exerted smaller effects on the majority of measured parameters. Probiotic treatment attenuated most of the physiological, inflammatory, and behavioral abnormalities induced by the combined US and DSS intervention. Conclusions: The mouse model employed here using both US and DSS recapitulated the progression of IBS to the IBD associated with ‘emotional stress’ and demonstrated upregulated gut and brain Gsk3β expression accompanying this transition. The described model provides a useful paradigm for investigating the mechanisms underlying the disease development from IBS- to IBD-like pathology.
- Open Access
- 9 April 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (11)
Western diet induces iron-dependent enteric neurodegeneration via ferroptosis
The Western diets (WD), high in saturated fats such as palmitic acid (PA), promotes enteric neurodegeneration and motility disorders. Using murine models, in vitro systems, and human myenteric ganglia, we investigated whether a WD and PA drive iron-dependent ferroptotic injury in the enteric nervous system (ENS). Mice were fed a control diet (CD) or a WD for 12 weeks, with or without systemic AAV9-MaCPNS2 delivery of Nfe2l2 to enteric neurons. Colonic motility was assessed by a bead expulsion assay. We assessed ferroptosis using convergent readouts including iron dysregulation (transferrin receptor 1 [TfR1], ferritin heavy chain 1 [FTH1], labile and mitochondrial iron [Fe 2+ ]), lipid peroxidation (C11-BODIPY and 4-hydroxynonenal [4-HNE]), glutathione peroxidase 4 (GPX4) suppression, and pharmacologic inhibition by ferrostatin 1 (Fer-1) in primary enteric neurons, murine myenteric plexuses, and human networks of myenteric ganglia (nhMPG). WD-fed mice exhibited delayed colonic transit, increased TfR1 and FTH1, and vulnerability of nNOS neurons; these changes were reversed by nuclear factor erythroid 2–related factor 2; (Nfe2l2, also known as Nrf2) overexpression. RNA-seq of PA-treated immortalized murine fetal enteric neurons (IM-FENs) revealed disrupted neurotransmitter signaling, reduced mitochondrial and antioxidant programs, and increased iron import and lipid peroxidation signatures. PA increased labile Fe 2+ , mitochondrial ROS, membrane depolarization, Ca 2+ dysregulation, 4-HNE, and mitoferrin 2 (Mfrn2), whereas Fer-1 preserved mitochondrial integrity, viability, and ENS function. In human nhMPG, PA induced enteric neuronal iron loading and ferroptosis, supporting the translational relevance to diet-associated enteric neuropathy.
- 9 April 2026
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (11)
Open AccessWestern diet induces iron-dependent enteric neurodegeneration via ferroptosis
The Western diets (WD), high in saturated fats such as palmitic acid (PA), promotes enteric neurodegeneration and motility disorders. Using murine models, in vitro systems, and human myenteric ganglia, we investigated whether a WD and PA drive iron-dependent ferroptotic injury in the enteric nervous system (ENS). Mice were fed a control diet (CD) or a WD for 12 weeks, with or without systemic AAV9-MaCPNS2 delivery of Nfe2l2 to enteric neurons. Colonic motility was assessed by a bead expulsion assay. We assessed ferroptosis using convergent readouts including iron dysregulation (transferrin receptor 1 [TfR1], ferritin heavy chain 1 [FTH1], labile and mitochondrial iron [Fe 2+ ]), lipid peroxidation (C11-BODIPY and 4-hydroxynonenal [4-HNE]), glutathione peroxidase 4 (GPX4) suppression, and pharmacologic inhibition by ferrostatin 1 (Fer-1) in primary enteric neurons, murine myenteric plexuses, and human networks of myenteric ganglia (nhMPG). WD-fed mice exhibited delayed colonic transit, increased TfR1 and FTH1, and vulnerability of nNOS neurons; these changes were reversed by nuclear factor erythroid 2–related factor 2; (Nfe2l2, also known as Nrf2) overexpression. RNA-seq of PA-treated immortalized murine fetal enteric neurons (IM-FENs) revealed disrupted neurotransmitter signaling, reduced mitochondrial and antioxidant programs, and increased iron import and lipid peroxidation signatures. PA increased labile Fe 2+ , mitochondrial ROS, membrane depolarization, Ca 2+ dysregulation, 4-HNE, and mitoferrin 2 (Mfrn2), whereas Fer-1 preserved mitochondrial integrity, viability, and ENS function. In human nhMPG, PA induced enteric neuronal iron loading and ferroptosis, supporting the translational relevance to diet-associated enteric neuropathy.